Procuraduría confirmed Nueva EPS negligence caused Kevin Acosta's death
The Attorney General's Office revealed that there was direct responsibility between Nueva EPS and the death of minor Kevin Arley Acosta Pico, who...
TL;DR
- The Attorney General's Office found Nueva EPS directly responsible for the death of Kevin Arley Acosta Pico, who suffered from hemophilia.
- The child died on February 13 due to the health provider's negligence in not supplying his vital medication, EMICIZUMAB.
- Kevin Arley Acosta Pico went without the medication for approximately two months because Medicarte, his attending IPS, suspended deliveries due to non-payment by Nueva EPS.
- The Attorney General's Office warned that approximately 2,000 other patients previously under Medicarte and Integral may be at high risk due to unsecured medical attention.
- A copy of the report will be sent to the Prosecutor's Office to investigate individuals responsible for the minor's death, and a disciplinary investigation will be initiated against Óscar Galvis, the interventor of Nueva EPS.
- The case highlights a broader crisis in the healthcare system, with reports of other patients with rare diseases dying due to difficulties in receiving essential services and medications.
- The president of the Colombian Hemophilia League stated that over 40 hemophilia patients are in a similar situation, and no deaths specifically due to lack of medication had occurred in over 20 years until recently.